Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

American Society of Plastic Surgeons Says Take the COVID-19 Vaccine, Even with Reports of Reactions from 3 Women with Derm Fillers
  • USA - English

Plastic Surgeon and skincare specialist Dr. Alexis Parcells agrees with the American Society of Plastic Surgeons and offers Tips on understanding the issues.


News provided by

American Society of Plastic Surgeons

Mar 17, 2021, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Alexis Parcells
Dr. Alexis Parcells

SHREWSBURY, N.J., Mar. 17, 2021 /PRNewswire-PRWeb/ -- The American Society of Plastic Surgeons (ASPS) has put out a statement advising its members not to discourage patients with dermal fillers from taking the Moderna COVID-19 vaccine. The guidance comes following reports that three patients with a history of dermal filler use who took the Moderna vaccine experienced some degree of lip or facial swelling as a side effect.

"I completely agree with the recommendation from the ASPS," notes New Jersey based Plastic Surgeon and skincare specialist Dr. Alexis Parcells, owner of Parcells Plastic Surgery. "The reports of reactions from the 3 women represents a tiny percentage of the population, the symptoms resolved quickly and the benefits of the COVID-19 vaccine far outweigh the described side effects", adds Dr. Parcells.

The risk is overhyped. Get the vaccine.

Post this

The ASPS also noted "in light of recent media coverage of the Moderna COVID-19 vaccine's associated side-effects noted in patients with dermal fillers, it is important for physicians and patients to understand the self-limited nature of these reported events. The current reported side effects have only been observed in the Moderna vaccine trial in 3 out of 15,184 recipients; it is currently unknown how many participants had a history of dermal filler usage." Moreover, ASPS offered that "dermal filler-associated delayed hypersensitivity immunologically based reactions have been reported for both hyaluronic acid and non-hyaluronic acid-based fillers. These reactions have specifically been demonstrated after influenza-like illness."

The FDA noted in its December 17th, 2020 report on the trials that in each of these cases, the swelling completely resolved.

What It All Means
Dr. Parcells explains that "most dermal fillers are broken down by the material used to create the gel that adds volume to the face. Either they are made with hyaluronic acid (a substance that is actually found naturally occurring in the body) or they are made with something else."

The ASPS is saying there have been instances where the immune system, responding to an "influenza-like illness," inadvertently targets the lip filler and fights it, too - causing swelling. These responses are "delayed hypersensitivity" because the body accepted the fillers just fine initially, then became sensitive to them when the immune response was triggered by an illness.

These instances happen regardless of whether the filler is made with hyaluronic acid or something else. Dr. Parcells offers that, "because vaccines work by making the body think that it's fighting an illness to trigger an immune response, it's not out of line to think that an immune system response to a vaccine like the COVID-19 vaccine might do the same thing."

According to the FDA, the patients who experienced these reactions make up less than .02% of the total number of patients tested. Dr. Parcells notes that "without knowing how many of the participants in the Moderna vaccine trials had a history of using dermal fillers, it is difficult to make evidence-based conclusions on the likelihood of other dermal filler patients experiencing similar side effects. The patients were not asked about their dermal fillers until the side effects presented, and a study on the Moderna vaccine specifically looking at the reactions of people with dermal fillers has not been conducted - yet."

Dr. Parcells worries about the negative impact from media outlets jumping to conclusions that people with dermal fillers are at risk of swelling if they take the Moderna vaccine and warns against false media reporting. Dr. Parcells points to a more even handed article in ALLURE Magazine in which it is reported that the vast majority of plastic surgeons note that the benefits of the Moderna Vaccine far out outweigh the potential risks of lip or facial swelling for dermal filler patients. Dr. Parcells continues to advise patients who use dermal fillers to get vaccinated.

"The opinion of the ASPS and plastic surgeons around the world is clear and unwavering," says Dr. Parcells. "If you do experience swelling, it can be easily treated with antihistamines and steroids. The potential side effects of getting COVID-19 are far worse than the vaccine. The risk is overhyped. Get the vaccine."

Bio: Alexis Parcells, MD, is a board-certified plastic surgeon and owner of Parcells Plastic Surgery. http://www.alexisparcellsmd.com

Media Contact

Melissa Chefec, MCPR, LLC, 2039686625, [email protected]

SOURCE American Society of Plastic Surgeons

Related Links

http://www.alexisparcellsmd.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.